Nuclear Medicine in 2024: A Year of Breakthroughs and Challenges
Nuclear medicine is entering a game-changing era. Breakthroughs in radiopharmaceuticals, cutting-edge clinical advancements, and surging investments are propelling the field forward.
Resources
Key Life Sciences Insights
Featured Resource
Our Scientific Articles
Access our library of peer-reviewed and conference publications for the latest scientific insights.
Our team of scientists, strategists, economists, clinicians, and biostatisticians stay on the cutting edge of the evolving landscape.
We collect their insights and the latest thinking and invite you to explore these resources.
We collect their insights and the latest thinking and invite you to explore these resources.
Creating Patient-Centric Clinical Trials in Rare Disease
For sponsors and CROs, patient engagement is critical. Explore specific opportunities for sponsors, CROs, and trial sites to develop patient-centric clinical trials for rare diseases.
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing detailed insights into pipelines, financial trends, and the impact of technological advancements.
The 2024 Global Antibody-Drug Conjugates Report
Gain comprehensive insights into the ADC market with our 2024 Global Antibody-Drug Conjugates Report. This in-depth analysis covers market trends, clinical development challenges, innovation opportunities, competitive dynamics, and strategic deals.
2024 Global Biosimilars Report
Download for an assessment of trends in the global biosimilar market, with an emphasis on market and competitive dynamics in the US and Europe.
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Success in rare disease requires an integrated approach, where development and commercialization are seamlessly connected, with patient access and partnerships as the primary focus from day one.
Value-Based Healthcare: Frequently Asked Questions
Explore expert answers to key questions on VBHC from the Global Payer Forum. Learn how to overcome barriers and drive implementation.
Tangible Ways Patient Insights Accelerate Access and Product Launch
This article explores how leveraging patient insights can help companies overcome market access barriers and improve their chances of success.
Heart Failure Medical Devices Market Landscape in 2025
Explore the forces shaping heart failure medical devices, the emerging technologies driving innovation, and the key challenges on the road ahead.
Beyond Patient Advisory Boards: Expanding Methods for Patient-Centered Insights in Healthcare
Explore innovative ways to gather patient insights for your product development beyond traditional advisor boards.
ATMPs: Access, Pricing, and Ethical Issues in Perspective
Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.
New Regulation on Health Technology Assessment: Impact in France
Discover the new Regulation on Health Technology Assessment impacts on market access processes in France.
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
This in-depth report explores emerging trends, competitive dynamics, market opportunities, cutting-edge innovations, and pivotal transactions shaping the antibody-drug conjugates (ADC) market.
Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
Alira Health, a global healthcare advisory and technology company, is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering initiative in the field of cancer prevention led by Gustave Roussy, one of the world’s top cancer research institutes.
Alira Health Launches SpherePX™, a Next-Generation Technology Platform to Advance Real-World Evidence
Alira Health announces the global launch of its innovative technology platform SpherePX, designed to drive real-world evidence (RWE) collection and elevate patient engagement and retention. This platform empowers organizations to seamlessly manage Phase 4 studies and patient registries, including post-authorization safety studies (PASS), effectiveness assessments, and comparative studies.
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona School of Management, the NEWDIGS at Tufts Medical Center and the University College of London, made possible through funding by Takeda.
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
This funding will drive Alira Health’s strategic growth, enhance its innovative technology platforms, and support solutions that empower patients and create value for life sciences companies.
Global Payer Forum 2025 Now On-Demand!
View this series of educational webinars on Value-Based Contracting led by payers and academic experts from around the world.
How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe
This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.
The Lupus Journey: Addressing Unmet Patient Needs
This webinar will help you translate insights of the lupus patient journey into value-added takeaways for your lupus asset.
Developing an Effective Regulatory Strategy for the Evolving 2024 Medtech Landscape
This webinar explores how to manage the growing regulatory demands and crucial differences between the EU and US regulatory landscapes, and the latest updates that could impact your business
Robotic-Assisted Surgery in Orthopedic Procedures: Current Landscape and 2024 Outlook
This webinar replay investigates the current RAS landscape with specific focus on adoption drivers, market dynamics, access challenges and more.
Global Pharma Builds an Early Payer Value Story for Radioligand Therapy in Brain Cancer
Our client sought help to connect with payers early, raise awareness about this new treatment, identify key evidence gaps for payers, and develop a mitigation plan.
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Family Office Optimizes Biosimilar Investments Through Strategic Capital Market Transaction
A client reached out to appropriately value two biosimilar assets, facilitate discussions with its management, and coordinate the capital market transaction as an asset-contribution in kind.
Pharma Expands European Footprint for UTI Prophylactic Treatment with Strategic Licensing
EQL Pharma saw an opportunity and sought support to market Memprex in the rest of Europe through strategic licensing agreements.